Early sexual initiation and long-term hormonal contraception
Cervical cancer risk in Makassar, Indonesia
DOI:
https://doi.org/10.24252/sociality.v5i1.60989Keywords:
cervical cancer, contraception, early sexual initiation, reproductive health, risk factorsAbstract
Cervical cancer remains a critical public health problem, particularly in low- and middle-income countries where access to early detection and prevention programs is limited. Previous studies have highlighted reproductive behaviors as important risk factors; however, region-specific evidence to inform targeted health interventions remains insufficient. This study aimed to examine the association between selected reproductive behaviors and cervical cancer incidence among women in Makassar, Indonesia. A cross-sectional analytic design was employed using medical record data from 147 women diagnosed with cervical cancer at Ibnu Sina Hospital between January 2023 and June 2024. Data were analyzed using chi-square tests and logistic regression to assess the relationships between early sexual initiation, number of sexual partners, long-term hormonal contraceptive use, and cervical cancer risk. The findings indicated that women who initiated sexual intercourse at or before the age of 20 were nearly four times more likely to develop cervical cancer. In addition, long-term use of hormonal contraception for more than five years was associated with a sixfold increase in risk. No significant association was observed between the number of sexual partners and cervical cancer, possibly due to sample homogeneity and reporting bias. These results underscore the importance of early reproductive health education and informed contraceptive counseling. Public health strategies should prioritize culturally sensitive education, human papillomavirus vaccination, and improved access to screening programs to reduce cervical cancer burden in similar settings.
References
Bramanulditya, R.A, Suwondo, P., & Widodo, D. (2018). Early marriage and cervical cancer risk in Indonesia. Asian Pacific Journal of Cancer Prevention, 19(8), 2203–2207.
Cosmas, T. M., Gumbi, D. N., & Mlay, R. (2023). Human papillomavirus infection within two years of sexual debut: A prospective study. BMC Infectious Diseases, 23(1), 44–51.
Damayanti, R Winarti, Y., & Fauziah, N. (2023). Hormonal contraceptive use and cervical cancer: A meta-analysis. Reproductive Health, 20(2), 105–112.
Dessia, A., & Siregar, A. (2022). The relationship between sexual behavior and cervical cancer incidence: A cross-sectional study in North Sumatra. Indonesian Journal of Public Health, 17(4), 234–240.
Dewi, R. K., Prasetyo, A., & & Yuniarti, K. (2020). Hormonal mechanisms in cervical carcinogenesis: Role of contraceptives. Journal of Medical Biology and Research, 8(2), 112–119.
Divia, S. P. (2024). Sociocultural influences on reporting sexual behavior in Indonesian women: Implications for cervical cancer research. Asian Social Science, 20(1), 89–96.
Enyan, E., Nyarko, S. H., & Fiscian, V. (2014). Risk factors for cervical cancer in Ghana: A case-control study. BMC Public Health, 14(1), 1–9.
Fahriani, M. (2023). Risk assessment of cervical cancer in Indonesian women: A retrospective review. Jurnal Epidemiologi Kesehatan Indonesia, 11(3), 65–72.
Gedefaw, A., Astatkie, A., & Tessema, G. A. (2013). The effect of multiple sexual partners on the risk of cervical cancer. International Journal of Women’s Health, 5(1), 85–92.
Haruna, N., Hatta, M., Hamid, F., Sultan, A. R., Farid, M. F., & Lestari, E. (2025). Prevalence of human papillomavirus type 6 and type 11 in pregnant women. 1, 5–9.
Iversen, O. E., Tjalma, W. A. A., & Willems, G. (2021). HPV persistence and hormone exposure in cervical neoplasia. The Lancet Oncology, 22(10), 1341–1350.
Jahanfar, S., Jaafar, S. H., & Ghazali, F. (2024). The reliability of self-reported sexual behavior in cervical cancer research. Malaysian Journal of Medical Sciences, 31(1), 56–65.
Kindi, N. M., Al-Balushi, A., & Al-Hatali, M. (2023). Duration of hormonal contraceptive use and cervical cancer risk: Evidence from Oman. International Journal of Reproductive Medicine, Article ID.
Louie, K. S., de Sanjose, S., & Mayaud, P. (2009). Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: A comprehensive review. Tropical Medicine & International Health, 14(10), 1287–1302.
Makuza, J. D., Nsanzimana, S., & Muhimpundu, M. A. (2015). Prevalence and risk factors of cervical cancer in Rwanda. BMC Women’s Health, 15(1), 1–8.
Mitra, A., Mitra, P., & Singh, A. (2023). Molecular mechanisms of HPV-induced cervical oncogenesis. Journal of Molecular Oncology, 17(2), 202–215.
Mullar, F., Qureshi, Z., & Chan, C. (2022). Cervical epithelial changes during adolescence: Susceptibility to HPV infection. Pediatrics and Adolescent Health., 6(1), 33–40.
Nadhiroh, S. R., Rahmah, M., & Astuti, P. (2021). Coverage of cervical cancer screening in Indonesia. Indonesian Journal of Health Policy, 5(4), 213–220.
Pulrnani, A., Herlina, D., & Puspita, R. (2021). The link between early marriage and cervical neoplasia in West Java. Women’s Health Review, 4(3), 88–95.
Rahmawati, L., Widodo, S., & Rizal, D. (2020). Bivariate and multivariate analyses in cervical cancer studies. Jurnal Biometrika Kesehatan Indonesia, 3(2), 102–109.
Sari, I. Y., Marlina, E., & Winarti, R. (2022). Barriers to cervical cancer screening participation in Indonesia. Asian Pacific Journal of Cancer Care, 7(1), 121–128.
Sharma, M. (2022). HPV vaccination and cervical cancer prevention: A global perspective. Journal of Cancer Policy, 32, 100329.
Sindiani, A. M., Tarawneh, M. R., & Alshdaifat, E. (2020). Hormonal contraceptives and cervical cancer: A regional analysis. Middle East Fertility Society Journal, 25(1), 1–7.
Sung, H., Ferlay, J., & Siegel, R. L. (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide. CA: A Cancer Journal for Clinicians, 71(3), 209–249.
Syahadat, R., Hadi, F. M., & Andriani, R. (2022). Hormonal imbalance and cervical epithelial transformation. Journal of Obstetrics and Gynecology Indonesia, 8(1), 55–64.
Syahputri, I., & Sugiharto, M. (2023). HPV vaccination in Indonesia: Policy and implementation challenges. Public Health in Southeast Asia, 12(2), 98–106.
Teklehaimanot, A., Kebede, T., & Nigussie, D. (2022). Duration of contraceptive use and cervical dysplasia risk: A case-control study. East African Medical Journal, 99(4), 251–257.
Tiiti, L. A., Mushemeza, S., & Ojwang, M. (2022). Risk factors for cervical precancerous lesions in Uganda. Journal of Reproductive Medicine in Africa, 3(1), 44–50.
Tran, N., Ly, K., & Andersson, M. (2020). Impact of HPV vaccination on cervical cancer incidence in Nordic countries. European Journal of Epidemiology, 35(9), 847–857.
Wahidin, M., Suryoputro, A., & Arifin, Z. (2022). Knowledge, attitudes, and practices toward cervical cancer screening among Indonesian women. BMC Women’s Health, 22(1), 315–323.
World Health Organization (WHO). (2020). Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem. Geneva: World Health Organization.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Taty Pilar Cahyani, Nadyah Haruna, Dewi Setiawati, Alifia Ayu Delima, Esa Lestari
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
